Open for Innovation: UK Biopharma R&D Sourcebook 2016

As the UK prepares to embark on a new path outside of the EU, we will need the best policies and resources to foster open innovation, the “outside in/inside out” flow of ideas that was a contrast to previously closed R&D corporate labs.

This is why ‘Open for Innovation’ is our theme for this year’s UK Biopharma R&D Sourcebook.

The Sourcebook aims to provide a snapshot of some of the key measures by which our industry develops medicines and the context in which this takes place.

We have this data grouped in four sections: Global health and the role of biopharma, Investing in innovation, Driving clinical research to deliver medicines, and Collaborating for innovation.